In line with HLA-E overexpression described in microsatellite instable tumors in colorectal cancer [38], we also reported a higher prevalence of HLA-E overexpression in HRD tumors that are known to be more immune infiltrated, due to their genomic instability. The gene discussed is HLA-E; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.